Bronstein, Gewirtz & Grossman, LLC Encourages Coupang, Inc. (CPNG) Investors to Inquire about Securities Investigation

NEW YORK CITY, NY / ACCESS Newswire / December 14, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Coupang, Inc. ("Coupang" or "the Company") (NYSE:CPNG). Investors who purchased Coupang securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/CPNG. Coupang […]

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against ModivCare, Inc. (MODV) and Encourages Shareholders to Learn More About the Investigation

NEW YORK CITY, NY / ACCESS Newswire / December 14, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ModivCare, Inc. ("ModivCare" or "the Company") (NASDAQ:MODV). Investors who purchased ModivCare securities prior to November 3, 2022, and continue to hold to the present, are encouraged to obtain additional

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against MGP Ingredients, Inc. (MGPI) and Encourages Shareholders to Learn More About the Investigation

NEW YORK CITY, NY / ACCESS Newswire / December 14, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of MGP Ingredients, Inc. ("MGP Ingredients" or "the Company") (NASDAQ:MGPI). Investors who purchased MGP Ingredients securities prior to May 4, 2023, and continue to hold to the present, are encouraged

Bronstein, Gewirtz & Grossman, LLC Is Investigating Molina Healthcare, Inc. (MOH) And Encourages Stockholders to Connect

NEW YORK CITY, NY / ACCESS Newswire / December 14, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Molina Healthcare, Inc. ("Molina" or "the Company") (NYSE:MOH). Investors who purchased Molina securities prior to February 5, 2025, and continue to hold to the present, are encouraged to obtain

GeeFi (GEE) Announces Upcoming DEX Focused on Smarter and User-Centric Trading

KINGSTOWN, St. Vincent and Grenadines, Dec. 14, 2025 (GLOBE NEWSWIRE) — GeeFi Tech LLC has officially disclosed the upcoming launch of its native Decentralized Exchange (DEX), marking a significant evolution in its comprehensive financial infrastructure. This development is engineered to offer participants a protected, high-speed, and autonomous trading interface. This news arrives during a phase

GeeFi (GEE) Announces Upcoming DEX Focused on Smarter and User-Centric Trading

GeeFi (GEE) Announces Upcoming DEX Focused on Smarter and User-Centric Trading GlobeNewswire December 14, 2025 KINGSTOWN, St. Vincent and Grenadines, Dec. 14, 2025 (GLOBE NEWSWIRE) — GeeFi Tech LLC has officially disclosed the upcoming launch of its native Decentralized Exchange (DEX), marking a significant evolution in its comprehensive financial infrastructure. This development is engineered to

Inside information: Bioretec has been granted FDA Breakthrough Device Designation status for its RemeOs™ DrillPin

Bioretec LtdInside information14 December 2025 at 5:45 p.m. EET Bioretec Oy (“Bioretec” or the “Company”), a pioneer in biodegradable orthopedic implants, has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA) for its magnesium alloy technology-based, biodegradable RemeOs™ DrillPin. The designation covers the RemeOs™ DrillPin for fixation of bone fragments in

Lost Money on James Hardie Industries plc. (JHX)? Urged to Join Class Action Before December 23, 2025 – Contact Levi & Korsinsky

NEW YORK, NY / ACCESS Newswire / December 14, 2025 / If you suffered a loss on your James Hardie Industries plc. (NYSE:JHX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://shareholderclaimcenter.com/james-hardie-industries-plc.-lawsuit-submission-form?prid=180259&wire=1&utm_campaign=22 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com

Levi & Korsinsky Notifies MoonLake Immunotherapeutics (MLTX) Shareholders of Class Action Lawsuit and December 15, 2025 Deadline

NEW YORK, NY / ACCESS Newswire / December 14, 2025 / If you suffered a loss on your MoonLake Immunotherapeutics (NASDAQ:MLTX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://stockdropcenter.com/moonlake-lawsuit-submission-form?prid=180249&wire=1&utm_campaign=15 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

Investor Alert: Deadline Approaching to Join Perrigo Company plc (PRGO) Class Action – Contact Levi & Korsinsky

NEW YORK, NY / ACCESS Newswire / December 14, 2025 / If you suffered a loss on your Perrigo Company plc (NYSE:PRGO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://shareholderclaimcenter.com/perrigo-company-plc-lawsuit-submission-form?prid=180250&wire=1&utm_campaign=25 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

Scroll to Top